Calico, Google's first major foray into biotech, has been quietly filling its ranks and fleshing out its mission in the months since its existence first came to light, bringing together industry luminaries to tackle the broad issue of aging.
Researchers have developed and are pilot testing an imaging pen that uses three different spectroscopic mechanisms to view a skin lesion. The device has the potential to identify suspected skin cancer tumors earlier and cut the costs of unnecessary biopsies.
Cannabis Therapy has partnered with Seattle-based Canna-Pet to produce cannabinoids for canines.
Over the past year, many tech heavyweights have begun moving into the mHealth sector. Developers got an early look at Google's offering this week, with the search giant releasing a preview version of its APIs for health app developers.
It took GlaxoSmithKline 30 years to get its new malaria vaccine ready for regulatory review. But global health officials--driven by a worldwide clamor--are excitedly pointing to GSK now as one of its prime candidates for getting a vaccine to fight Ebola in a matter of months.
Sanofi has reached out to Seattle biotech Immune Design, looking to borrow the company's drug discovery platform to develop new treatments for food allergies.
Japanese drugmaker Astellas Pharma has teamed up with Cancer Research U.K. to join forces on early-stage oncology R&D, working to identify new treatments for pancreatic cancer.
Google released a preview of its software development kit for fitness apps on Aug. 7. The software will interact with wearable devices and enable a variety of apps to benefit from information about a user's fitness history stored on a centralized interface.
A U.S. research team has made progress toward creating a biomarker blood test that can detect esophageal cancer on the early side, a major need in order to combat the lethal disease.
Over the past year a clutch of startups have talked up their ability to automate aspects of R&D by matching software to robotic technologies. But the ambitions of some groups go well beyond these examples, with researchers aiming to create robo-chemists.